Adult-onset vitelliform macular dystrophy
Other Names for this Disease
- Adult-onset foveomacular dystrophy
- Adult-onset foveomacular dystrophy with choroidal neovascularization
- Adult-onset foveomacular vitelliform dystrophy
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
On this page
Management for this condition should include a comprehensive eye examination, including dilation, once or twice a year to rule out any possible complications. If vision is impaired, patients should be referred for low vision testing and rehabilitation. Intravitreal injections of either Ranibizumab or Bevacizumab may be effective in the short-term. Transcorneal electrical stimulation has also been found to improve visual acuity in individuals with this condition.
Last updated: 3/31/2014
- Chan, S and Macdonald I. Adult-onset foveomacular vitelliform dystrophy. Orphanet. December 2013; http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=99000. Accessed 3/31/2014.
- Ozeki N, Shinoda K, Ohde H et al. Improvement of visual acuity after transcorneal electrical stimulation in case of Best vitelliform macular dystrophy.. Graefes Arch Clin Exp Ophthalmol. April 19, 2013; 251(7):1867-70. http://www.ncbi.nlm.nih.gov/pubmed/23604515. Accessed 3/31/2014.
- Orphanet lists European clinical trials, research studies, and patient registries enrolling people with this condition.